✕
Login
Register
EN
Translate page
EN
English
ES
Español
FR
Français
DE
Deutsch
ZH
中文
AR
العربية
PT
Português
RU
Русский
JA
日本語
KO
한국어
HI
हिन्दी
IT
Italiano
Back to News
Vistagen Says Fasedienol Well-Tolerated Up To 12 Months In Preliminary Open-Label Extension Of Phase 3 Social Anxiety Trial; Plans FDA Meeting This Quarter On New Phase 3
Benzinga Newsdesk
www.benzinga.com
Positive 93.5%
Neg 0%
Neu 0%
Pos 93.5%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment